Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
AKBA
Stock Latest News
The Fly
Akebia, IRC announce broad availability of Vafseo across IRC dialysis clinics
8d ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Reports Record Revenue and Strategic Growth
17d ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Reports Strong Q2 2025 Growth
22d ago
AKBA
Premium
The Fly
Akebia reports Q2 EPS 0c vs (4c) last year
22d ago
AKBA
Premium
Ratings
Strategic Partnerships and Clinical Trials Propel Akebia Therapeutics’ Growth Potential
23d ago
AKBA
Premium
Pre-Earnings
Akebia Therapeutics (AKBA) Q2 Earnings Cheat Sheet
24d ago
AKBA
Premium
The Fly
Akebia initiates post-marketing study to identify benefits of Vafseo
25d ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Approves Stock Plan Amendment at Meeting
3M ago
8K
AKBA
Premium
Weekend Updates
International Paper, ImmunityBio, Agenus, Akebia, Apple: Trending by Analysts
3M ago
IP
AAPL
Premium
The Fly
Akebia announces JASN published analysis from vadadustat phase 3 program
3M ago
AKBA
Premium
Ratings
Buy Rating for Akebia Therapeutics Driven by VAFSEO’s Market Potential in CKD Anemia
3M ago
AKBA
Premium
The Fly
Akebia assumed with a Buy at H.C. Wainwright
3M ago
AKBA
Premium
Ratings
Akebia Therapeutics’ Growth Potential Driven by Vafseo’s Market Expansion and Upcoming VALOR Trial
3M ago
AKBA
Premium
Ratings
Akebia Therapeutics: Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
4M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Reports Strong Q1 2025 Performance
4M ago
AKBA
Premium
Company Announcements
Akebia Therapeutics Reports Strong Vafseo Launch Success
4M ago
AKBA
Premium
The Fly
Akebia reports Q1 EPS 3c vs (9c) last year
4M ago
AKBA
Premium
Pre-Earnings
AKBA Earnings this Week: How Will it Perform?
4M ago
AKBA
Premium
Weekend Updates
Cognex, Editas, Akebia, Tvardi, Chipotle: Trending by Analysts
4M ago
CMG
AKBA
Premium
The Fly
Akebia initiated with an Outperform at Leerink
4M ago
AKBA
Premium
Ratings
Strategic Developments and Market Opportunities Drive Buy Rating for Akebia Therapeutics
5M ago
AKBA
Premium
The Fly
Akebia announces CHMP positive opinion for XOANACYL
5M ago
AKBA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
